Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|September 4, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint componentsMonique B Nilsson, Huiying Sun, Jacqulyne Robichaux, et al.
JTO Clinical and Research Reports|July 30, 2026
Clinical Activity of RET TKI Plus Chemotherapy After Progression on a RET TKI in a RET Fusion-Positive NSCLC Real-World Cohort: A Brief ReportAlvaro Guimaraes Paula, Ximeng Liu, Amirali Karimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 TrialMarcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLCNatalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Journal for Immunotherapy of Cancer|June 24, 2025
Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancerKyle G Mitchell, Younghee Lee, Nathaniel Deboever, et al.
Journal of Thoracic Disease|July 10, 2020
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancersErin M Corsini, Jinliang Wang, Chia-Chin Wu, et al.
JTO Clinical and Research Reports|March 31, 2025
Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNASimon Heeke, Saumil Gandhi, Hai T Tran, et al.
The New England Journal of Medicine|June 3, 2022
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRAS MutationPasi A Jänne, Gregory J Riely, Shirish M Gadgeel, et al.
Pageof 6